uniQure

189 articles about uniQure

• uniQure Announces Pricing Of Initial Public Offering

  2/5/2014

• Gene Therapy Biopharma uniQure Sets Terms For $64 Million IPO

  1/27/2014

• uniQure Announces Confidential Submission of Draft Registration Statement for Initial Public Offering

  11/11/2013

• uniQure to Build 55,000 Square Foot State-of-the-Art Gene Therapy Production Plant in U.S. to Leverage AAV-Manufacturing Strength

  7/30/2013

• uniQure Announces Start of Parkinson's Disease Gene Therapy Phase I Trial by University of California, San Francisco (UCSF)/National Institutes of Health (NIH) to Test Its GDNF Gene in Patients

  7/29/2013

• uniQure, Chiesi Farmaceutici SpA Strike $58 Million Deal for Hemophilia B Development

  7/9/2013

• European Commission (EC) OKs uniQure's First High-Price Gene Therapy for Rare Disease

  11/2/2012

• First Gene Therapy in Western World From uniQure Receives Positive Opinion in Europe from CHMP

  7/20/2012

• uniQure Extends Collaboration with Protein Sciences Corporation on Use of its expresSF+® Cell Line for Gene Therapy

  6/19/2012